F.D.A. Panel Recommends Vaccine for Children 5 to 11
Covid-19 was “the eighth-highest killer of kids in this age group over the past year,” said a C.D.C. official in favor of broader authorization. (Source: NYT Health)
Source: NYT Health - October 27, 2021 Category: Consumer Health News Authors: Sharon LaFraniere and Noah Weiland Tags: Children and Childhood Pfizer Inc Vaccination and Immunization Coronavirus (2019-nCoV) Coronavirus Risks and Safety Concerns Disease Rates Food and Drug Administration United States Politics and Government Centers for Disease Control and P Source Type: news

FDA Panel Votes to Approve Pfizer ’s Vaccine for Children
The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA. (Source: WebMD Health)
Source: WebMD Health - October 26, 2021 Category: Consumer Health News Source Type: news

FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for young children (Source: ABC News: Health)
Source: ABC News: Health - October 26, 2021 Category: Consumer Health News Tags: Health Source Type: news

FDA Panel Votes to Approve Pfizer's Vaccine for Children FDA Panel Votes to Approve Pfizer's Vaccine for Children
Despite some questions and concerns, the advisory panel felt the benefits outweighed the risks for children 5-11.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

FDA Committee Recommends COVID-19 Vaccine for Children 5-11 Years Old
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults. The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - October 26, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Louisiana ’s governor lifts the state’s indoor mask mandate except in schools.
But he cautioned that the pandemic is not over and that the state lags far behind in vaccinations. (Source: NYT Health)
Source: NYT Health - October 26, 2021 Category: Consumer Health News Authors: Adeel Hassan Tags: Disease Rates Masks Coronavirus (2019-nCoV) Vaccination and Immunization Centers for Disease Control and Prevention Pfizer Inc Louisiana Source Type: news

FDA advisory panel recommends the Pfizer vaccine to be authorized for children 5 to 11
An FDA panel has unanimously voted to recommend the Pfizer-BioNTech Covid vaccine for authorization for children aged five to 11. It would be the first jab available for that age. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2021 Category: Consumer Health News Source Type: news

FDA advisory committee recommends authorizing Pfizer's COVID vaccine for kids
The U.S. Food and Drug Administration isn't bound by the committee's recommendation, but is expected to consider it and make a decision in the coming days on whether to approve the vaccine for kids five to 11 years old. (Source: CBC | Health)
Source: CBC | Health - October 26, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

FDA panel backs Pfizer Covid-19 vaccine for 5- to 11-year-olds
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 26, 2021 Category: Pharmaceuticals Source Type: news

FDA advisers endorse Pfizer’s COVID-19 vaccine for children ages 5 to 11.
FDA advisers endorse Pfizer’s COVID-19 vaccine for children ages 5 to 11. (Source: ABC News: Health)
Source: ABC News: Health - October 26, 2021 Category: Consumer Health News Tags: Health Source Type: news

FDA panel recommends Pfizer's low-dose Covid vaccine for kids ages 5 to 11
The endorsement was a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads. (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2021 Category: Consumer Health News Source Type: news

COVID-19 Boosters Are Now More Popular Than First Shots
When Americans divide themselves into camps, they stick to them fiercely: Democrats versus Republicans, pro-life versus pro-choice, gun rights versus gun control. Add to that, as has become apparent over the course of the past year, those who are pro- versus anti-coronavirus vaccines. As with so many other polarizing issues, your position on getting or not getting inoculated against COVID-19 has become more than a medical question. It’s morphed into a form of cultural identifier, a sign of your membership in one tribe or another. More than ever, that’s becoming clear as booster shots are rolled out around the n...
Source: TIME: Health - October 26, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Source Type: news

FDA advisers review Pfizer’s COVID-19 vaccine for kids
U.S. health advisers are deliberating whether kid-size doses of Pfizer's COVID-19 vaccine are safe and effective in young children (Source: ABC News: Health)
Source: ABC News: Health - October 26, 2021 Category: Consumer Health News Tags: Health Source Type: news

FDA panel weighs Pfizer Covid-19 jabs for 5-11 year olds
Biden administration says younger kids could get shots within weeks if it gets US regulator’s approval (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 26, 2021 Category: Pharmaceuticals Source Type: news

Virginia governor race, Pfizer vaccine goes before panel, World Series: 5 things to know Tuesday
President Biden will campaign for Terry McAuliffe in Virginia, a panel will review Pfizer-BioNTech's data for kids' vaccine and more... (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2021 Category: Consumer Health News Source Type: news

U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in children
The age group is "far from being spared from the harm of COVID-19," with the virus now one of the top 10 causes of deaths in American children, FDA official Peter Marks told the panel. He said there had been close to 100 deaths in that age group so far, and 1.9 million infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 26, 2021 Category: Pharmaceuticals Source Type: news

Are Vaccine Boosters Widely Needed? Some Federal Advisers Have Misgivings.
“In our hearts, I think people don’t quite agree with this notion of a booster dose,” said one leading vaccine expert. (Source: NYT Health)
Source: NYT Health - October 25, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Food and Drug Administration Moderna Inc BioNTech SE Pfizer Inc Johnson & Source Type: news

Moderna Reports COVID-19 Vaccine Safe and Efficacious for Kids
Moderna’s COVID-19 vaccine is safe and efficacious for children ages 6 to 11 years old who recieve two half doses, the company said today. That’s based on the results of its KidCOVE study, which involved more than 4,700 kids in that age group. The children participating in Moderna’s trial were randomly assigned to receive two half doses of the vaccine or two shots of a placebo. Those who got the vaccine generated adequate virus-fighting antibodies that met the U.S. Food and Drug Administration’s (FDA) requirements for efficacy, and the vaccine produced an immune response in nearly all the children. ...
Source: TIME: Health - October 25, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Moderna Says Vaccine Produces Powerful Immune Response in Those 6 Through 11
The results were announced a day before an advisory committee of the Food and Drug Administration is scheduled to review data for the Pfizer-BioNTech vaccine in children 5 through 11. (Source: NYT Health)
Source: NYT Health - October 25, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Children and Childhood Moderna Inc Source Type: news

Scientists link Covid vaccines to rare neurological complications
Study finds Pfizer and Oxford/AstraZeneca jabs have infrequent association with seven illnesses (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 25, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccines associated with 7 rare neurological complications, says study
Researchers emphasise that adverse events following Pfizer and AstraZeneca jabs are extremely rare (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 25, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccines associated with rare neurological complications, says study
Researchers emphasise that adverse events following Pfizer and AstraZeneca jabs are extremely rare (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 25, 2021 Category: Pharmaceuticals Source Type: news

China to Start Vaccinating Children Over 3 Years Old as COVID-19 Cases Spread
(TAIPEI, Taiwan) — Children as young as 3 will start receiving COVID-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks. Local city and provincial level governments in at least five provinces issued notices in recent days announcing that children ages 3-11 will be required to get their vaccinations. The expansion of the vaccination campaign comes as parts of China take new clampdown measures to try to stamp out small outbreaks. Gansu, a northwestern province heavily dependent on tourism, closed all tourist sites Monday a...
Source: TIME: Health - October 25, 2021 Category: Consumer Health News Authors: Huizhong Wu / AP Tags: Uncategorized China COVID-19 healthscienceclimate wire Source Type: news

Are Vaccine Boosters Widely Needed? Some Federal Advisers Have Misgivings
“In our hearts, I think people don’t quite agree with this notion of a booster dose,” said one leading vaccine expert. (Source: NYT Health)
Source: NYT Health - October 25, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Food and Drug Administration Moderna Inc BioNTech SE Pfizer Inc Johnson & Source Type: news

Pfizer and BioNTech announce Phase 3 trial data showing high efficacy of a booster dose of their COVID-19 vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age and older. In the trial, a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster. (Source: World Pharma News)
Source: World Pharma News - October 25, 2021 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Pfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDA
Title: Pfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDACategory: Health NewsCreated: 10/23/2021 12:00:00 AMLast Editorial Review: 10/25/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - October 25, 2021 Category: Pediatrics Source Type: news

Coronavirus Vaccines Should Begin Soon for Children 5 and Up
An advisory panel to the F.D.A. will consider Pfizer ’s application for those ages 5-to-11 on Tuesday. (Source: NYT Health)
Source: NYT Health - October 25, 2021 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Children and Childhood Johnson & Moderna Inc Pfizer Inc Fauci, Anthony S United States Source Type: news

WHO's advisory group set to meet on October 26 to decide on Covaxin EUL approval
While the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson& Johnson-Janssen, Moderna, and Sinopharm for emergency use, Covaxin's approval is awaited. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 25, 2021 Category: Pharmaceuticals Source Type: news

F.D.A. Says Pfizer Vaccine ’s Benefits Outweigh Key Risks in Children 5 to 11
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps as early as next week, a long-awaited development that would affect 28 million children. (Source: NYT Health)
Source: NYT Health - October 24, 2021 Category: Consumer Health News Authors: Sharon LaFraniere and Noah Weiland Tags: Clinical Trials Coronavirus (2019-nCoV) Vaccination and Immunization Children and Childhood Coronavirus Risks and Safety Concerns Pfizer Inc BioNTech SE Food and Drug Administration Source Type: news

Pfizer bullied, blackmailed government officials to push covid vaccines and maximize corporate profits
(Natural News) Public Citizen has published a report that outlines how drug giant Pfizer created secret contracts and used its monopoly power to manipulate governments into buying and dispensing its Wuhan coronavirus (Covid-19) “vaccines.” As one of the top vaccine producers under “Operation Warp Speed,” Pfizer used its position of power to “silence governments, throttle... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2021 Category: Consumer Health News Source Type: news

FDA says Pfizer vaccine appears to work in young kids; virus infections in UK remain at 'unacceptable' level: Live COVID updates
Pfizer’s COVID vaccine appears highly effective at preventing symptomatic infections in young kids and caused no unexpected safety... (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2021 Category: Consumer Health News Source Type: news

FDA Says Pfizer COVID-19 Vaccine Looks Effective for Young Kids
Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters. The Food and Drug Administration posted its analysis of Pfizer’s data ahead of a public meeting next week to debate whether the shots are ready for the nation’s roughly 28 million children ages 5 to 11. The agency will ask a panel of outside vaccine experts to vote on that question. In their analysis, FDA scientists concluded that...
Source: TIME: Health - October 23, 2021 Category: Consumer Health News Authors: LAURAN NEERGAARD and MATTHEW PERRONE / AP Tags: Uncategorized COVID-19 wire Source Type: news

Elizabeth Holmes sent to Walgreens a doctored report that made it look like Pfizer had endorsed Theranos' technology
Theranos founder Elizabeth Holmes sent executives at Walgreen Boots Alliance Inc. a report that had been altered to make it look — falsely — like Pfizer Inc. had endorsed the startup's blood testing technology, according to evidence introduced at Holmes' fraud trial Friday. The report pertained to a 15-month study that began in 2007 that looked at the response of late-stage cancer patients to certain treatments, The Wall Street Journal reported. The patients were provided with Theranos testing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2021 Category: Biotechnology Authors: Troy Wolverton Source Type: news

FDA says kid-sized Pfizer vaccine doses appear highly effective, safe
U.S. health regulators say kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the country weighs beginning vaccinations in youngsters. (Source: CBC | Health)
Source: CBC | Health - October 23, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

FDA says Pfizer COVID vaccine looks effective for young kids
Federal scientists say kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections among elementary school children (Source: ABC News: Health)
Source: ABC News: Health - October 23, 2021 Category: Consumer Health News Tags: Health Source Type: news

Elizabeth Holmes sent to Walgreens a doctored report that made it look like Pfizer had endorsed Theranos' technology
Theranos founder Elizabeth Holmes sent executives at Walgreen Boots Alliance Inc. a report that had been altered to make it look — falsely — like Pfizer Inc. had endorsed the startup's blood testing technology, according to evidence introduced at Holmes' fraud trial Friday. The report pertained to a 15-month study that began in 2007 that looked at the response of late-stage cancer patients to certain treatments, The Wall Street Journal reported. The patients were provided with Theranos testing… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2021 Category: Pharmaceuticals Authors: Troy Wolverton Source Type: news

Pfizer Vaccine for Kids 90% effective in Preventing COVID-19
As of the first week of October, 16 participants in the placebo group had gotten a symptomatic, lab-confirmed COVID-19 infection compared with just three who caught COVID in the vaccinated group. (Source: WebMD Health)
Source: WebMD Health - October 22, 2021 Category: Consumer Health News Source Type: news

COVID-19 delta plus variant could require even MORE vaccines, says Pfizer board member
(Natural News) Scott Gottlieb said on Monday, Oct. 18, that the new delta plus variant (AY.4) of the Wuhan coronavirus (COVID-19) could require more booster shots. According to Gottlieb’s Twitter post, the delta plus variant may have “partial immune evasion,” which was cited as a reason for people needing booster shots during the delta variant panic earlier... (Source: NaturalNews.com)
Source: NaturalNews.com - October 22, 2021 Category: Consumer Health News Source Type: news

Pfizer Data Show Vaccine for Kids 90% Effective in Preventing COVID Pfizer Data Show Vaccine for Kids 90% Effective in Preventing COVID
The Pfizer vaccine for kids ages 5-11 is 10 micrograms, roughly one third of the dose given to adolescents and adults.WebMD Health News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - October 22, 2021 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Pfizer says Covid-19 vaccine more than 90% effective in kids
The shots could begin in early November. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 22, 2021 Category: Biotechnology Source Type: news

Pfizer says Covid-19 vaccine more than 90% effective in kids
Editor's note: This story is available as a result of a content partnership with WFTV. Subscribers will see stories like this on our website and in our daily emails as an added value to your subscription. Kid-size doses of Pfizer’s Covid-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November —… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 22, 2021 Category: American Health Source Type: news

The U.S. Promised 1.1 Billion Covid-19 Vaccine Doses To Poorer Countries. Here ’s Where They Are Going.
The White House marked donating 200 million doses Thursday, most of which have been mRNA vaccines produced by Pfizer and Moderna. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 22, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news

Pfizer says COVID-19 vaccine more than 90% effective in kids
Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing symptomatic infections in elementary school children (Source: ABC News: Health)
Source: ABC News: Health - October 22, 2021 Category: Consumer Health News Tags: Health Source Type: news

Pfizer says studies show COVID-19 vaccine over 90% effective in kids 5-11
Studies show that child-sized doses of Pfizer's COVID-19 vaccine are safe and better than 90% effective in kids between 5 and 11 years old, the pharma company said Friday as regulators consider authorizing the shots. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 22, 2021 Category: Consumer Health News Source Type: news

Pfizer Says Its COVID-19 Vaccine Appears More Than 90% Effective in Kids
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators give the go-ahead. Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its independent review of the company’s safety and effectiveness data later in the day. Advisers to the FDA will pub...
Source: TIME: Health - October 22, 2021 Category: Consumer Health News Authors: Lauran Neergaard and Matthew Perrone / AP Tags: Uncategorized COVID-19 wire Source Type: news

Pfizer, BioNTech Report High Efficacy of COVID-19 Booster Shot in Study Pfizer, BioNTech Report High Efficacy of COVID-19 Booster Shot in Study
A booster dose of the COVID-19 vaccine developed by Pfizer and German partner BioNTech restored efficacy to 95.6% against disease caused by the virus, including the Delta variant.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Young men under 30 who receive the Moderna vaccine are more likely to develop heart inflammation
The CDC revealed data on Thursday showing that young men who receive the Moderna COVID-19 vaccine are slightly more likely to develop heart inflammation than those who get the Pfizer jab. (Source: the Mail online | Health)
Source: the Mail online | Health - October 22, 2021 Category: Consumer Health News Source Type: news

Pfizer says COVID-19 vaccine more than 90% effective in kids
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to... (Source: Reuters: Health)
Source: Reuters: Health - October 22, 2021 Category: Consumer Health News Source Type: news

Antivirals for COVID-19: five questions that must be answered, Pharmaceutical Journal
Furthest ahead is molnupiravir, an oral agent from MSD. Candidates from Pfizer& Roche/Atea not far behind, with further announcements expected in coming weeks. Article looks at whether these antivirals really make a difference, who will get them and how much they will cost. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 22, 2021 Category: Consumer Health News Source Type: news

HORROR: In order to make covid vaccines, Pfizer cuts open live babies without anesthesia to harvest tissues
(Natural News) A disturbing, but not surprising, revelation has surfaced about how Pfizer harvested organs and other body parts from live babies in order to produce Wuhan coronavirus (Covid-19) “vaccines.” Whistleblower Melissa Strickler, who works as a manufacturing quality auditor for Pfizer, recently came forward with internal company emails revealing the horrific practices that Pfizer... (Source: NaturalNews.com)
Source: NaturalNews.com - October 22, 2021 Category: Consumer Health News Source Type: news